• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Genetics of gigantism and acromegaly.巨人症和肢端肥大症的遗传学
Growth Horm IGF Res. 2016 Oct-Dec;30-31:37-41. doi: 10.1016/j.ghir.2016.08.002. Epub 2016 Aug 10.
2
Screening for genetic causes of growth hormone hypersecretion.筛查生长激素分泌过多的遗传原因。
Growth Horm IGF Res. 2016 Oct-Dec;30-31:52-57. doi: 10.1016/j.ghir.2016.10.004. Epub 2016 Oct 12.
3
[Old phenotype and new genotypes. Pituitary adenomas].[旧表型与新基因型。垂体腺瘤]
Rev Med Liege. 2015 Nov;70(11):569-74.
4
Familial gigantism.家族性巨人症。
Clinics (Sao Paulo). 2012;67 Suppl 1(Suppl 1):29-32. doi: 10.6061/clinics/2012(sup01)06.
5
Familial acromegaly - case study of two sisters with acromegaly.家族性肢端肥大症——两例肢端肥大症姐妹的病例研究。
Endokrynol Pol. 2011;62(6):554-7.
6
Gigantism: X-linked acrogigantism and GPR101 mutations.巨人症:X连锁肢端巨大症与GPR101突变
Growth Horm IGF Res. 2016 Oct-Dec;30-31:64-69. doi: 10.1016/j.ghir.2016.09.007. Epub 2016 Sep 29.
7
Pituitary gigantism: Causes and clinical characteristics.垂体巨人症:病因及临床特征。
Ann Endocrinol (Paris). 2015 Dec;76(6):643-9. doi: 10.1016/j.ando.2015.10.002. Epub 2015 Nov 14.
8
Pituitary Acrogigantism: From the Past to the Future.垂体肢端巨大症:从过去到未来。
Front Horm Res. 2024;55:82-97. doi: 10.1159/000539941.
9
Loss of heterozygosity on chromosome 11q13 in two families with acromegaly/gigantism is independent of mutations of the multiple endocrine neoplasia type I gene.两个肢端肥大症/巨人症家族中11q13染色体杂合性缺失与多发性内分泌腺瘤I型基因的突变无关。
J Clin Endocrinol Metab. 1999 Jan;84(1):249-56. doi: 10.1210/jcem.84.1.5370.
10
Genetics of Acromegaly and Gigantism.肢端肥大症和巨人症的遗传学
J Clin Med. 2021 Mar 29;10(7):1377. doi: 10.3390/jcm10071377.

引用本文的文献

1
Oral Health and Quality of Life in Acromegaly: A Questionnaire-Based Study.肢端肥大症患者的口腔健康与生活质量:一项基于问卷调查的研究
Dent J (Basel). 2025 May 22;13(6):226. doi: 10.3390/dj13060226.
2
Case report: Management of pediatric gigantism caused by the TADopathy, X-linked acrogigantism.病例报告:X 连锁肢端巨大症导致的儿童巨人症的治疗。
Front Endocrinol (Lausanne). 2024 Feb 28;15:1345363. doi: 10.3389/fendo.2024.1345363. eCollection 2024.
3
Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: Part 1, general recommendations.儿童和青少年垂体腺瘤诊断和管理的共识指南:第 1 部分,一般建议。
Nat Rev Endocrinol. 2024 May;20(5):278-289. doi: 10.1038/s41574-023-00948-8. Epub 2024 Feb 9.
4
A worldwide bibliometric analysis of acromegaly in the past two decades: 1999-2022.过去二十年(1999 - 2022年)全球肢端肥大症的文献计量分析
Front Neurosci. 2023 Jul 5;17:1187820. doi: 10.3389/fnins.2023.1187820. eCollection 2023.
5
Growth hormone receptor agonists and antagonists: From protein expression and purification to long-acting formulations.生长激素受体激动剂和拮抗剂:从蛋白表达和纯化到长效制剂。
Protein Sci. 2023 Sep;32(9):e4727. doi: 10.1002/pro.4727.
6
Delving into Acromegaly.深入探究肢端肥大症。
J Clin Med. 2023 Feb 19;12(4):1654. doi: 10.3390/jcm12041654.
7
Development and evaluation of the Acromegaly Symptom Diary.肢端肥大症症状日记的制定与评估。
J Patient Rep Outcomes. 2023 Feb 15;7(1):15. doi: 10.1186/s41687-023-00541-7.
8
The cAMP-signaling cancers: Clinically-divergent disorders with a common central pathway.cAMP 信号通路相关癌症:具有共同核心通路的临床差异显著的疾病。
Front Endocrinol (Lausanne). 2022 Oct 13;13:1024423. doi: 10.3389/fendo.2022.1024423. eCollection 2022.
9
Genetic and Epigenetic Pathogenesis of Acromegaly.肢端肥大症的遗传和表观遗传发病机制
Cancers (Basel). 2022 Aug 10;14(16):3861. doi: 10.3390/cancers14163861.
10
Genome of a giant isopod, Bathynomus jamesi, provides insights into body size evolution and adaptation to deep-sea environment.巨型等足目动物深海大虱基因组揭示了体型演化和对深海环境适应的机制。
BMC Biol. 2022 May 13;20(1):113. doi: 10.1186/s12915-022-01302-6.

本文引用的文献

1
Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study.胚系或体细胞 GPR101 重复导致 X 连锁肢端巨大症:临床病理和遗传学研究。
Acta Neuropathol Commun. 2016 Jun 1;4(1):56. doi: 10.1186/s40478-016-0328-1.
2
Somatic GPR101 Duplication Causing X-Linked Acrogigantism (XLAG)-Diagnosis and Management.体细胞GPR101重复导致X连锁肢端巨大症(XLAG)——诊断与管理
J Clin Endocrinol Metab. 2016 May;101(5):1927-30. doi: 10.1210/jc.2015-4366. Epub 2016 Mar 16.
3
Analysis of GPR101 and AIP genes mutations in acromegaly: a multicentric study.肢端肥大症中 GPR101 和 AIP 基因突变的分析:一项多中心研究。
Endocrine. 2016 Dec;54(3):762-767. doi: 10.1007/s12020-016-0862-4. Epub 2016 Jan 27.
4
Very low frequency of germline GPR101 genetic variation and no biallelic defects with AIP in a large cohort of patients with sporadic pituitary adenomas.在一大群散发性垂体腺瘤患者中,生殖系GPR101基因变异的频率极低,且不存在与AIP相关的双等位基因缺陷。
Eur J Endocrinol. 2016 Apr;174(4):523-30. doi: 10.1530/EJE-15-1044. Epub 2016 Jan 20.
5
Incidence and prevalence of acromegaly in a large US health plan database.美国一个大型健康计划数据库中肢端肥大症的发病率和患病率。
Pituitary. 2016 Jun;19(3):262-7. doi: 10.1007/s11102-015-0701-2.
6
GHRH excess and blockade in X-LAG syndrome.X连锁肢端肥大症综合征中的生长激素释放激素过量与阻断
Endocr Relat Cancer. 2016 Mar;23(3):161-70. doi: 10.1530/ERC-15-0478. Epub 2015 Dec 15.
7
Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients.垂体巨人症的临床与遗传学特征:一项针对208例患者的国际合作研究
Endocr Relat Cancer. 2015 Oct;22(5):745-57. doi: 10.1530/ERC-15-0320. Epub 2015 Jul 17.
8
Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers.家族性孤立性及青年型垂体腺瘤的概况:AIP 突变携带者的前瞻性诊断
J Clin Endocrinol Metab. 2015 Sep;100(9):E1242-54. doi: 10.1210/jc.2015-1869.
9
Carney complex: an update.卡尼综合征:最新进展
Eur J Endocrinol. 2015 Oct;173(4):M85-97. doi: 10.1530/EJE-15-0209. Epub 2015 Jun 30.
10
X-linked acrogigantism syndrome: clinical profile and therapeutic responses.X连锁肢端巨大症综合征:临床特征与治疗反应
Endocr Relat Cancer. 2015 Jun;22(3):353-67. doi: 10.1530/ERC-15-0038. Epub 2015 Feb 24.

巨人症和肢端肥大症的遗传学

Genetics of gigantism and acromegaly.

作者信息

Hannah-Shmouni Fady, Trivellin Giampaolo, Stratakis Constantine A

机构信息

Section on Endocrinology & Genetics (SEGEN), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Bethesda, MD 20892, USA.

Section on Endocrinology & Genetics (SEGEN), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Bethesda, MD 20892, USA.

出版信息

Growth Horm IGF Res. 2016 Oct-Dec;30-31:37-41. doi: 10.1016/j.ghir.2016.08.002. Epub 2016 Aug 10.

DOI:10.1016/j.ghir.2016.08.002
PMID:27657986
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5154831/
Abstract

Gigantism and acromegaly are rare disorders that are caused by excessive GH secretion and/or high levels of its mediator, IGF-1. Gigantism occurs when excess GH or IGF-1 lead to increased linear growth, before the end of puberty and epiphyseal closure. The majority of cases arise from a benign GH-secreting pituitary adenoma, with an incidence of pituitary gigantism and acromegaly of approximately 8 and 11 per million person-years, respectively. Over the past two decades, our increasing understanding of the molecular and genetic etiologies of pituitary gigantism and acromegaly yielded several genetic causes, including multiple endocrine neoplasia type 1 and 4, McCune-Albright syndrome, Carney complex, familial isolated pituitary adenoma, pituitary adenoma association due to defects in familial succinate dehydrogenase genes, and the recently identified X-linked acrogigantism. The early diagnosis of these conditions helps guide early intervention, screening, and genetic counseling of patients and their family members. In this review, we provide a concise and up-to-date discussion on the genetics of gigantism and acromegaly.

摘要

巨人症和肢端肥大症是罕见的疾病,由生长激素(GH)分泌过多和/或其介质胰岛素样生长因子-1(IGF-1)水平升高引起。当青春期结束和骨骺闭合之前,过量的GH或IGF-1导致线性生长增加时,就会发生巨人症。大多数病例源于良性分泌GH的垂体腺瘤,垂体巨人症和肢端肥大症的发病率分别约为每百万人年8例和11例。在过去二十年中,我们对垂体巨人症和肢端肥大症的分子和遗传病因的认识不断增加,发现了多种遗传病因,包括1型和4型多发性内分泌腺瘤病、McCune-Albright综合征、Carney综合征、家族性孤立性垂体腺瘤、由于家族性琥珀酸脱氢酶基因缺陷导致的垂体腺瘤关联,以及最近发现的X连锁肢端肥大症。这些疾病的早期诊断有助于指导患者及其家庭成员的早期干预、筛查和遗传咨询。在本综述中,我们对巨人症和肢端肥大症的遗传学进行了简明且最新的讨论。